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Purpose: This study was designed to measure the effect of intermittent pneumatic 
compression fthe plantar venous plexus on popliteal vein (PV) and common femoral vein 
(CFV) velocities measured by duplex ultrasound scanning. 
Methods: Thirty lower limbs in 15 healthy vohmteers had venous duplex scanning 
measurement of PV and CFV velocities before and during foot pumping with an 
arteriovenous impulse foot pump system. Venous velocities were measured at two pump 
pressure settings (100 mm Hg, 200 mm Hg) and during two pump impulse durations 
(short = I second, normal = 3 seconds). All limbs were examined with the subjects in the 
supine position, and then measurements were repeated with subjects in the 15-degree 
reverse Trendelenburg position. The mean maximum venous velocity (MVV) produced by 
foot pumping was compared with resting venous velocity at each anatomic location and 
for each technologic variable. 
Results: Impulse foot pumping produced a statistically significant increase in MVV in both 
the PV and the CFV compared with resting velocities. This significant increase was 
observed for both pressure settings and both impulse durations, and no differences 
produced by these two individual variables could be detected. The increase in MVV 
produced by foot pumping was similar for limbs in the supine position and those xamined 
in the reverse Trendelenburg position. The percentage increase in MVV produced by foot 
pumping was significantly higher in the PV than in the CFV. 
Conclusions: Intermittent pneumati~ compression of the plantar venous plexus produces 
measurable increases in venous outflow from the lower limbs of normal subjects. This 
study seems to justify further evaluation of the effectiveness of this technique for 
mechanical deep venous thrombosis prophylaxis in selected high-risk patient groups. 
(J VASC SURG 1995;22:598-605.) 
Deep venous thrombosis (DVT) and pulmonary 
embolism (PE) remain a significant cause of morbid- 
ity and death in the United States and worldwide. It 
has been estimated that in the United States alone, 
DVT and PE account for 300,000 to 600,000 hos- 
pital admissions each year and that as many as 50,000 
deaths occur annually as a result of PE. 1 Fatal PE 
remains asignificant risk in adult patients undergoing 
major surgical procedures. 
Groups of patients at higher isk for DVT and PE 
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have been identified, 1 and numerous techniques for 
DVT prophylaxis have been investigated to reduce 
the incidence of DVT and PE in thesc patients at 
higher isk. Effective DVT prophylaxis has generally 
taken two forms: antithrombotic medications to 
reduce the hypercoagulable state in patients at high 
risk, and mechanical leg compression devices to 
reduce venous tasis. Antithrombotic chemoprophy- 
laxis has included low-molecular-weight dextran, 
warfarin, 2 low-dose unfractionated heparin, 3 and 
low-molecular-weight heparin. 4 Although the abso- 
lute effect of risk reduction has varied in different 
unique high-risk groups with these varied antithrom- 
boric regimens, overall they are recognized to be 
effective for DVT prophylaxis. However, in almost 
every study antithrombotic prophylaxis has been 
associated with a higher risk of bleeding complica- 
tions, and these treatments have been avoided in 
clinical groups where bleeding might produce an 
undue risk, such as patients with major trauma and 
patients undergoing neurosurgcry. 
JOURNAL OF VASCULAR SURGERY 
Volume 22, Number 5 IGllewich et aL 599 
Fig. 1. A, RV tracing from PV before foot pumping. Measured RV was recorded from 
maximum velocity of this phasic spectral pattern. B, Venous velocity tracing from CFV after 
short impulse foot pumping at 100 mm Hg with subject in supine position. MVV was measured 
at peak deflection from baseline. 
Lower limb intermittent pneumatic compression 
(IPC) devices have also provided effective DVT and 
PE prophylaxis in patients at high risk undergoing 
general surgical, s-8 neurosurgical, 9~1° orthopedic, 11'12 
and urologic surgical procedures. 13,14 Additionally 
IPC devices have been used extensively for effective 
DVT prophylaxis in patients with trauma, ls-18 These 
devices have not been associated with bleeding or 
other major surgical complications. However, in 
cases of lower limb surgery or trauma, IPC devices 
may not be able to be effectively applied to the limbs. 
Other patients consider IPC cumbersome and un- 
comfortable. This has led to the investigation of 
alternative limb compression devices that might 
provide DVT prophylaxis in these patients. 
The mechanism of action of IPC devices is 
primarily to reduce venous tasis by increased venous 
outflow from the limb. This has been accomplished 
in most devices by mechanical compression ofthe calf 
muscles or the sequential compression of the calf and 
thigh. 19-21 In 1983 Gardner and Fox 22 demonstrated 
the existence of a physiologic venous pumping 
mechanism in the plantar surface of the foot that 
emptied rapidly when weight-bearing flattened the 
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Table I. MVV in the CFV of control subjects during impulse foot pumping at two pressure 
settings (100 mm Hg, 200 mm Hg), with two impulse durations (S and N) and in two 
examination positions (supine, reverse Trendlenberg) 
Position Resting 100 mm Hg-S 100 mm Hg-N 200 mm Hg-S 200 mm Hg-N 
Supine 27.1 + 1.6 51.1 + 2.3 47.7 _+ 2.0 50.5 + 2.5 48.9 _+ 2.4 
Reverse Trendelenburg 24.6 + 1.4 50.2 _+ 2.5 50.2 _+ 2.3 48.7 _+ 2.2 48.6 + 2.0 
S, Short; N, normal. 
Values are mean velocity in cm/sec _+ SEM. 
plantar arch. Blood from the plantar venous plexus 
was transmitted upward through the deep venous 
system resulting in increased venous outflow. These 
observations led to the development of a mechanical 
device (A-V Impulse System; NovamedLx, England; 
Kendall Healthcare Inc., Mansfield, Mass.) to com- 
press the venous plexus of the foot and simulate the 
physiologic pumping mechanism of normal ambula- 
tion. This study was performed to assess the effect of 
impulse foot pumping on lower limb venous outflow 
in normal volunteers with duplex ultrasound scan- 
ning measurements of femoral and popliteal venous 
velocities. 
MATERIAL AND METHODS 
Subjects. Measurement ofvenous velocities was 
performed in 30 legs of 15 normal volunteers 
without history or clinical evidence of venous dys- 
function. There were eight women and seven men 
with a mean age of 35 years. All patients underwent 
routine venous duplex ultrasound scanning to ex- 
clude DVT or major venous valvular dysfunction. 
A-V Impulse pump. All subjects had foot 
pumping performed with a commercially available 
A-V Impulse unit. The device consists of an electri- 
cally driven air compressor and air reservoir that vents 
into an inflation pad mounted in a foot cover. When 
inflated, the pad compresses and empties the plantar 
venous plexus. The impulse begins with a rapid 
pressure rise in the first 0.4 sec which is then held for 
either a 1-second (short) or 3-second (normal) total 
pressure impulse. The device produces an impulse 
every 20 seconds and is adjustable to pressures of 80 
to 120 mm Hg (100 mm setting) or 160 to 200 mm 
Hg (200 mm setting). It should be noted that the 
hemodynamics of the impulse foot pump are con- 
siderably different from traditional intermittent 
pneumatic ompression devices that have a much 
longer inflation period (11 to 60 seconds) at lower 
pressures (35 to 50 mm Hg) with compression cycles 
every minute in most cases. 
Venous duplex scanning. Duplex scanning mea- 
surements of venous velocities (centimeters/second) 
were performed with a commercially available ultra- 
sound unit (HDI-UM 9; Advanced Technology 
Laboratories, Bothell, Wash.). Popliteal veins (PV) 
were examined irectly behind the knee joint with the 
subject in the supine position, the hip externally 
rotated, and the knee slightly flexed. Common 
femoral vein (CFV) measurements were taken ap- 
proximately 2 cm cephalad to the saphenofemoral 
junction with the patient in the supine position and 
the leg extended in a neutral position. 
Technique. Volunteers were initially placed in 
the supine position, and the foot pads of the A-V 
impulse pump were applied to both feet. Foot 
pumping was performed for a period of 5 to 10 
minutes in each case before initiating duplex scan- 
ning measurements. Several cycles of the pump were 
observed in both the PV and CFV of each limb 
before each measurement to ensure stable duplex 
imaging and sampling. Resting venous velocities 
(RV) were measured in each limb as the maximum 
venous velocity of the phasic venous cycle recorded 
between cycles of the foot pump (Fig. 1, A). 
Maximum venous velocities (MVV) from the PV 
and CFV were measured from the spectral velocity 
pattern recorded by duplex scanning during impulse 
pumping (Fig. 1, B). Velocity measurements were 
performed at each of the two pressure settings (100 
mm, 200 mm-above) and with each of the two 
impulse durations (short, normal-above) at each 
anatomic location. All measurements were first re- 
corded in the PV and then in the CFV of one leg, 
and similar measurements were then made in the 
contralateral limb of each subject. 
After examination with the subject in the supine 
position, measurements of venous velocities were 
repeated in all subjects with the examination cart in 
the 15- to 20-degree reverse Trendelenburg position 
because it has been proposed that this position may 
facilitate more effective filling of the plantar venous 
plexus and yield more efficient foot pumping. Three 
individual measurements of MVV were made in each 
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Fig. 2. Mean RV was significantly higher in CFV than in PV. Resting velocities were slightly 
lower with patients in reversed Trendelenburg position, but this difference was not statistically 
significant. 
Table II. MVV in the PV of control subjects during impulse foot pumping at two pressure 
settings (100 mm Hg, 200 mm Hg), with two impulse durations (S and N) and in two 
examination positions (supine, reverse Trendlenberg) 
Position Resting 100 mm Hg-S 100 mm Hg-N 200 mm Hg-S 200 mm Hg-N 
Supine 27.[l ± 1.6 51.1 ± 2.3 47.7 ± 2.0 50.5 ± 2.5 48.9 ± 2.4 
Reverse Trendelenburg 24.6 -+ 1.4 50.2 ± 2.5 50.2 ± 2.3 48.7 -+ 2.2 48.6 ± 2.0 
S, Short; N, normal. 
Values are mean velocity in cm/sec ± SEM. 
limb, in both anatomic locations at all settings. Thus 
a total of 12 measurements of MW were recorded at 
both anatomic locations in each limb during exami- 
nations with the subjects in the two separate posi- 
tions. Overall each subject had foot pumping per- 
formed for approximately 90 to 120 minutes during 
the entire period of measurement. 
Mean values of RV and MVV for each position, 
anatomic location, pressure, and impulse cycle were 
calculated for all limbs in the groups, and values are 
expressed as mean velocities + SEM (Tables I and 
II). Mean velocities were compared by use of the 
Student t test for paired variables, and differences 
were considered significant if they exceeded the 95% 
confidence level (p < 0.05). 
RESULTS 
RV. The mean resting velocity in the popliteal 
vein of the control subject in the supine position 
was 12.02 _+ 0.58 cm/sec. Popliteal RV in subjects 
in the reverse Trendelenburg position was slightly 
lower at 11.16 -+ 0.73 cm/sec, but this difference 
was not statistically significant. CFV mean RV was 
27.1 +_ 1.64 cm/sec with the subject in the supine 
position and was not significantly different from 
that measured with the subject in the reverse Tren- 
delenburg position; 24.62 _+ 1.4 cm/sec (Fig. 2). 
RV was significantly higher in the CFV than in the 
PV in subjects in both testing positions 
(p < 0.001). 
MVV. The mean MVV in the CFV and PV for 
each variable in subjects in both examination po- 
sitions are listed in Tables I and II. During impulse 
foot pumping statistically significant increases 
(p < 0.001) in mean MVV were observed in both 
the PV and CFV. These significant increases in 
venous velocities were noted at both pressure set- 
tings (100 mm Hg, 200 mm Hg), at both impulse 
cycles (short and normal), and in both examination 
positions (supine, reverse Trendelenburg) as seen in 
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Fig. 3. Statistically significant increase in MVV was produced by impulse foot pumping in 
both PV and CFV. This increase was observed at both pressure settings (100 mm Hg, 200 mm 
Hg) and for both pressure impulse durations (S represents 1 second; N represents 3 seconds). 
Position of subject during foot pumping had no significant effect on measured increases in
MVV. 
Fig. 3. Individual paired comparisons were per- 
formed on the measured mean MVV for each set 
of variables. There were no statistically significant 
differences in MVV measured uring impulse foot 
pumping in any setting with one exception. PV 
MVV with the subject in the supine position at 100 
mm Hg with a short impulse (47.47 + 1.85 cm/ 
sec) was significantly higher than that measured 
with the normal impulse duration (43.9 + 1.4 cm/ 
sec, p < 0.015). The percentage increase in MVV 
over resting velocity (Fig. 4) was significantly 
greater in the PV (278% supine position, 330% 
reverse Trendelenburg position) than in the CFV 
(83% supine position, 101% reverse Trendelenburg 
position). During the examination one of the 
subjects reported any discomfort from the impulse 
foot pumps referable to any of the variable settings 
used during this assessment. 
DISGUSSION 
Intermittent pneumatic ompression devices are 
recognized to provide effective prophylaxis against 
DVT and PE in most clinical settings. The mecha- 
nism of action of these devices is assumed to be 
largely due to reduced lower limb venous tasis that 
results from the mechanical pumping of the calf and 
thigh musculature. Some studies have reported a 
systemic enhancement of the intrinsic fibrinolytic 
system that may also be a secondary benefit of 
IPC. 2326 However, most critical investigations and 
technical modifications have centered on document- 
ing or improving the effectiveness of the pumping 
mechanism of IPC devices. 
Venous outflow from the limbs can be assessed 
invasively by dynamic phlebography, 22 27 but this is 
unrealistic in the large studies necessary to document 
the statistical efficacy of any individual device. 
Noninvasive assessment of venous outflow has been 
performed with strain-gauge plethysmography, s'is 
but this technique does not allow measurement of
venous flow in specific anatomic segments of the deep 
venous system. Nicolaides et al. 2° used hand-held 
transcutaneous continuous-wave Doppler and ob- 
served asignificant increase in femoral vein velocities 
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Fig. 4. Percentage increase inMVV compared with RV during foot pumping was significantly 
greater in PV than in CFV. However, these differences may only reflect differences in RV at 
these two anatomic locations. 
in normal volunteers during intermittent pneumatic 
compression of the legs. Similar findings were 
reported by Salvian and Baker 19 using continuous- 
wave Doppler to measure increased femoral vein 
velocities produced by IPC devices. Keith et al. 2] used 
venous duplex ultrasound scanning to specifically 
measure peal< venous velocity in the superficial 
femoral vein during leg pumping with various IPC 
devices. Duplex ultrasound scanning has the advan- 
tage over other noninvasive techniques because it 
allows discrete anatomic visualization of major axial 
segments of the deep venous system and image- 
directed hemodynamic measurements. In this study 
venous duplex scanning allowed measurement and 
comparison of venous velocity changes in the PV and 
CFV after alteration of a variety of technologic 
variables associated with the impulse foot pump. 
Similar to previous studies of conventional IPC 
devices, the impulse foot pump produce significant 
measurable increases in popliteal and femoral venous 
velocities. 
Because the predominant mechanism of action of 
IPC devices is assumed to be increased venous 
outflow, it has been logical to assume that techno- 
logic modifications designed to improve the hemo- 
dynamic efficacy of these devices will improve their 
effectiveness for DVT prophylaxis. Thus many in- 
vestigations of IPC devices have involved evaluation 
of the impact of these modifications on venous 
outflow measurements. Nicolaides et al. 2° reported 
that a greater increase in peak venous velocity was 
produced by a sequential, multichamber calf- and 
thigh-length device compared with a single-chamber 
calf pump (although the difference was not statisti- 
cally significant). However, in subsequent clinical 
trials reported in that study, there was a significantly 
lower incidence of proximal DVT in patients treated 
with the sequential IPC device. Keith et al.21 com- 
pared increases in femoral venous velocities produced 
by a variety of different IPC technologies, including 
calf-length single-stage IPC pumps and thigh-length 
sequential compression devices. Peak femoral venous 
velocities were significantly increased over RV during 
treatment with any of the IPC devices in their study. 
However, the peak venous velocities measured in 
limbs treated with the more technologically complex 
thigh-length, sequential compression devices were 
not statistically significantly greater than that ob- 
served uring treatment with the simpler calf-length 
device. Interestingly the peak venous velocities mea- 
sured by venous duplex scanning in the proximal 
superficial femoral vein in the study by Keith et al.21 
(45.5 to 59.8 cm/sec) is strikingly similar to the 
maximum venous velocity in the CFV observed in 
this study during impulse foot pumping alone (47.7 
to 51.1 cm/sec). Salzman et al. 23 observed that a 
four-compartment, ankle-to-knee, sequential exter- 
nal pneumatic compression device produced the 
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optimal hemodynamic effect in terms of venous flow 
rate, blood velocity, and wall shear stress that would 
be logical predictors of optimal DVT prophylaxis. 29 
However, despite optimized hemodynamic param- 
eters and an observed increase in intrinsic fibrinolytic 
activity with the more complex IPC device, these 
investigators did not demonstrate superior DVT 
prophylaxis over simpler, conventional IPC devices. 
Overall, increasing technologic complexity of IPC 
devices increases both the cost of these treatments 
and the potential for technical misadventure in their 
routine clinical applications. This does not seem to be 
accompanied by a measurable improvement in the 
efficacy of DVT prophylaxis. In fact, it appears that 
simpler devices that produce a measurable increase in 
venous outflow will achieve equally successful DVT 
prophylaxis. In this study impulse foot pumping was 
observed to produce significant increases in maxi- 
mum venous velocities in both the popliteal and 
femoral veins comparable to those previously re- 
ported for currently available IPC devices. 
One of the great benefits of IPC for DVT 
prophylaxis is that these devices have almost negli- 
gible complications compared with antithrombotic 
chemoprophylaxis. Nevertheless, ome patients can- 
not have or will not tolerate standard thigh- or 
calf-length IPC because of lower extremity surgery or 
trauma. In these cases a foot pump would be useful, 
but only if it was proven to provide equivalent DVT 
prophylaxis in similar high-risk groups. It should be 
emphasized that this study did not evaluate the foot 
pump for DVT prophylaxis but only measured 
changes in lower limb venous velocities, and then 
only in normal individuals. The A-V Impulse foot 
pump system has been reported to provide effective 
DVT prophylaxis in high-risk orthopedic surgical 
procedures, a°a2 However, this system has not been 
evaluated extensively in patients with major trauma 
or other recognized high-risk patient groups. This 
study examined normal subjects where clinical con- 
ditions that might compromise venous outflow from 
the limb (e.g., respiratory failure, heart failure, or 
extrinsic venous compression from pelvic or retro- 
peritoneal trauma) were absent. The significant 
increases in PV and CFV velocities observed in this 
study during impulse foot pumping compare favor- 
ably with past reports with other 1PC devices that 
have been proven clinically effective for DVT pro- 
phylaxis. However, our findings in normal volunteers 
do not in any way establish the efficacy of the foot 
pump for DVT prophylaxis. These findings appear to 
justify the further prospective evaluation of the 
impulse foot pump for DVT prophylaxis, especially 
in those patients who cannot be treated with standard 
antithrombotic therapy or other intermittent pneu- 
matic compression devices. 
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